Quantitative imaging of airway liquid absorption in cystic fibrosis

European Respiratory Journal

Volumn 44, Issue 3, 2014, Pages 675-684

  Locke, Landon W ^a   Myerburg, Michael M ^a   Markovetz, Matthew R ^b   Parker, Robert S ^b   Weber, Lawrence ^c   Czachowski, Michael R ^d   Harding, Thomas J ^d   Brown, Stefanie L ^a   Nero, Joseph A ^b   Pilewski, Joseph M ^a   Corcoran, Timothy E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Pittsburgh   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDIUM 111; IVACAFTOR; PENTETATE INDIUM IN 111; PENTETIC ACID; TECHNETIUM 99M; AEROSOL; RADIOPHARMACEUTICAL AGENT; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AIRWAY LIQUID ABSORPTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGE QUALITY; IN VITRO STUDY; LUNG FLUID; MUCOCILIARY CLEARANCE; NEBULIZER; NONSENSE MUTATION; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; AEROSOL; CASE CONTROL STUDY; CELL CULTURE; CHEMISTRY; CHILD; FEMALE; IMAGE PROCESSING; MALE; MIDDLE AGED; MUTATION; OSMOSIS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SCINTISCANNING; SPIROMETRY; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AEROSOLS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MUTATION; OSMOSIS; PENTETIC ACID; RADIOPHARMACEUTICALS; SPIROMETRY; TECHNETIUM TC 99M SULFUR COLLOID; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907379954     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00220513     Document Type: Article

References (27)

1. Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004; 23: 146-158.
2. Eckford PD, Li C, Ramjeesingh M, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner. J Biol Chem 2012; 287: 36639-36649.
3. McPhail GL, Clancy JP. Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis. Drugs Today (Barc) 2013; 49: 253-260.
4. Fajac I, Hubert D, Bienvenu T, et al. Relationships between nasal potential difference and respiratory function in adults with cystic fibrosis. Eur Respir J 1998; 12: 1295-1300.
5. 99mTc-DTPA from the bronchial mucosa. Am Rev Respir Dis 1989; 139: 1132-1138.
6. Donaldson SH, Bennett WD, Zeman KL, et al. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med 2006; 354: 241-250.
7. Robinson M, Regnis JA, Bailey DL, et al. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996; 153: 1503-1509.
8. Blouquit S, Regnier A, Dannhoffer L, et al. Ion and fluid transport properties of small airways in cystic fibrosis. Am J Respir Crit Care Med 2006; 174: 299-305.
9. Chambers LA, Rollins BM, Tarran R. Liquid movement across the surface epithelium of large airways. Respir Physiol Neurobiol 2007; 159: 256-270.
10. Corcoran TE, Thomas KM, Brown S, et al. Liquid hyper-absorption as a cause of increased DTPA clearance in the cystic fibrosis airway. EJNMMI Res 2013; 3: 14.
11. Corcoran TE, Thomas KM, Myerburg MM, et al. Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway. Eur Respir J 2010; 35: 781-786.
12. Donaldson SH, Corcoran TE, Laube BL, et al. Mucociliary clearance as an outcome measure for cystic fibrosis clinical research. Proc Am Thorac Soc 2007; 4: 399-405.
13. Bennett WD, Laube BL, Corcoran T, et al. Multisite comparison of mucociliary and cough clearance measures using standardized methods. J Aerosol Med Pulm Drug Deliv 2013; 26: 157-164.
14. Robinson M, Daviskas E, Eberl S, et al. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur Respir J 1999; 14: 678-685.
15. Regnis JA, Robinson M, Bailey DL, et al. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med 1994; 150: 66-71.
16. Myerburg MM, Harvey PR, Heidrich EM, et al. Acute regulation of the epithelial sodium channel in airway epithelia by proteases and trafficking. Am J Respir Cell Mol Biol 2010; 43: 712-719.
17. Hurt K, Bilton D. Inhaled mannitol for the treatment of cystic fibrosis. Exp Rev Respir Med 2012; 6: 19-26.
18. Harvey PR, Tarran R, Garoff S, et al. Measurement of the airway surface liquid volume with simple light refraction microscopy. Am J Respir Cell Mol Biol 2011; 45: 592-599.
19. 99mTc DTPA in respiratory tract mucus glycoprotein from patients with chronic bronchitis. Thorax 1988; 43: 669-673.
20. Donaldson SH, Boucher RC. Sodium channels and cystic fibrosis. Chest 2007; 132: 1631-1636.
21. 113mIn-DTPA aerosol clearances in humans. Effects of smoking, hyperinflation, and in vitro oxidation. Am Rev Respir Dis 1987; 136: 1112-1116.
22. Ulrich M, Worlitzsch D, Viglio S, et al. Alveolar inflammation in cystic fibrosis. J Cyst Fibros 2010; 9: 217-227.
23. Li X, Comellas AP, Karp PH, et al. CFTR is required for maximal transepithelial liquid transport in pig alveolar epithelia. AJP Lung Cell Mol Physiol 2012; 303: L152-L160.
24. + absorption in wild-type and ΔF508 CFTR-expressing human bronchial epithelia. Am J Physiol 1999; 276: C827-C837.
25. Nilsson HE, Dragomir A, Lazorova L, et al. CFTR and tight junctions in cultured bronchial epithelial cells. Exp Mol Pathol 2010; 88: 118-127.
26. LeSimple P, Liao J, Robert R, et al. Cystic fibrosis transmembrane conductance regulator trafficking modulates the barrier function of airway epithelial cell monolayers. J Physiol 2010; 588: 1195-1209.
27. Robinson M, Eberl S, Tomlinson C, et al. Regional mucociliary clearance in patients with cystic fibrosis. J Aerosol Med 2000; 13: 73-86.